Go Pro
→ Trump goes 'all-in' on Grand Canyon energy breakthrough (From Behind the Markets) (Ad)tc pixel Free INDP Stock Alerts

Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume

Indaptus Therapeutics logo
$3.77 -0.22 (-5.51%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$3.85 +0.08 (+2.12%)
As of 07:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Indaptus Therapeutics Short Interest Overview

As of August 31, 2026, Indaptus Therapeutics (INDP) had a short interest of 212,357 shares sold short, representing 0.18% of the public float. This marks a 71.62% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.2, meaning it would take 0.2 days of the average trading volume of 1.47 million shares to cover all short positions.

Current Short Interest
212,357 shares
Previous Short Interest
123,737 shares
Change Vs. Previous Month
71.62%
Dollar Volume Sold Short
$243.15 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
133,240,000 shares
Short Percent of Float
0.18%
Today's Trading Volume
624,549 shares
Average Trading Volume
1,469,423 shares
Today's Volume Vs. Average
43%
Short Selling Indaptus Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

INDP Short Interest Over Time

INDP Days to Cover Over Time

INDP Percentage of Float Shorted Over Time

Indaptus Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2026212,357 shares $243.15 thousand +71.6%0.2%0.15 $1.15
8/14/2026123,737 shares $132.40 thousand +32.9%0.1%0.91 $1.07
7/31/202693,141 shares $120.15 thousand -64.1%0.1%1.06 $1.29
7/15/2026259,720 shares $732.41 thousand +88.8%0.3%3.42 $2.82
6/30/2026137,594 shares $412.78 thousand -72.1%0.2%0.57 $3.00
6/15/2026493,245 shares $1.82 million +2,767.7%0.6%0.1 $3.69
5/29/202617,200 shares $30.27 thousand -71.4%0.0%0.13 $1.76
5/15/202660,118 shares $95.59 thousand -14.6%0.1%0.94 $1.59
4/30/202670,403 shares $197.13 thousand +33.9%4.1%1.61 $2.80
4/15/202652,565 shares $142.45 thousand +294.5%0.1%0.5 $2.71
3/31/202613,325 shares $24.25 thousand +54.2%0.0%0.74 $1.82
3/13/20268,642 shares $15.30 thousand -55.7%0.5%0.11 $1.77
2/27/202619,488 shares $40.15 thousand +8.6%1.1%1.12 $2.06
2/13/202617,943 shares $31.58 thousand -7.4%0.0%0.51 $1.76
1/30/202619,386 shares $42.65 thousand -71.5%1.1%0.27 $2.20
1/15/202668,026 shares $205.44 thousand -73.9%4.0%0.48 $3.02
12/31/2025260,406 shares $757.78 thousand +1,371.1%15.6%0.07 $2.91
12/15/202517,701 shares $40.89 thousand +25.9%1.3%0.45 $2.31
11/28/202514,057 shares $32.54 thousand +27.2%1.0%0.3 $2.32
11/14/202511,053 shares $27.74 thousand -5.0%1.3%0.29 $2.51
10/31/202511,629 shares $37.45 thousand -35.0%1.3%0.17 $3.22
10/15/202517,900 shares $69.45 thousand -91.2%1.8%0 $3.88
9/30/2025203,200 shares $583.18 thousand -62.9%20.3%0.4 $2.87
9/15/2025547,300 shares $1.25 million +3,524.5%54.7%4.7 $2.28
8/31/202515,100 shares $98.15 thousand -19.3%1.5%0.1 $6.50
8/15/202518,700 shares $143.52 thousand +64.0%2.1%0.1 $7.68
7/31/202511,400 shares $93.02 thousand -22.5%2.4%0 $8.16
7/15/202514,700 shares $179.19 thousand -50.8%3.1%0.1 $12.19
6/30/202529,900 shares $314.85 thousand -96.0%5.2%0.1 $10.53
6/15/2025748,000 shares $242.95 thousand -26.7%5.8%0.1 $0.32
5/31/20251,020,000 shares $343.33 thousand +1,157.7%7.9%1.5 $0.34
5/15/202581,100 shares $34.06 thousand -32.4%0.6%0.2 $0.42
4/30/2025119,900 shares $55.15 thousand -8.5%0.9%0.3 $0.46
4/15/2025131,100 shares $66.11 thousand -40.7%1.0%0.3 $0.50
3/31/2025221,200 shares $121.64 thousand +322.1%1.9%0.6 $0.55
3/15/202552,400 shares $42.19 thousand -10.0%0.5%0.1 $0.81
2/28/202558,200 shares $48.83 thousand -25.9%0.5%2.5 $0.84
2/15/202578,500 shares $62.72 thousand +102.8%0.7%3.1 $0.80
1/31/202538,700 shares $35.22 thousand -41.7%0.4%1.6 $0.91
1/15/202566,400 shares $57.77 thousand -11.2%0.7%0.6 $0.87
Elon gets it. Do you? (Ad)

Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.tc pixel

Stream the free Ignition Point broadcast for the full biotech breakdown.
12/31/202474,800 shares $62.99 thousand -19.1%0.8%0.7 $0.84
12/15/202492,500 shares $92.50 thousand +0.5%1.0%0.8 $1.00
11/30/202492,000 shares $93.84 thousand +8.2%1.1%0.8 $1.02
11/15/202485,000 shares $94.35 thousand -38.7%1.1%0.8 $1.11
10/31/2024138,700 shares $162.28 thousand +348.9%1.9%1.3 $1.17
10/15/202430,900 shares $39.24 thousand -9.7%0.4%0.3 $1.27
9/30/202434,200 shares $42.41 thousand +284.3%0.5%2.5 $1.24
9/15/20248,900 shares $13.44 thousand +140.5%0.1%0.7 $1.51
8/31/20243,700 shares $6.10 thousand -47.9%0.1%0.3 $1.65
8/15/20247,100 shares $11.86 thousand -12.4%0.1%0.4 $1.67
7/31/20248,100 shares $16.52 thousand -42.6%0.1%0.4 $2.04
7/15/202414,100 shares $31.02 thousand +147.4%0.2%0.7 $2.20
6/30/20245,700 shares $12.08 thousand +9.6%0.1%0.2 $2.12
6/15/20245,200 shares $12.84 thousand -66.7%0.1%0.2 $2.47
5/31/202415,600 shares $36.97 thousand -6.0%0.3%0.5 $2.37
5/15/202416,600 shares $36.69 thousand -35.7%0.3%0.2 $2.21
4/30/202425,800 shares $55.99 thousand -70.1%0.4%0.3 $2.17
4/15/202486,200 shares $228.43 thousand -13.9%1.5%1 $2.65
3/31/2024100,100 shares $224.22 thousand +0.7%1.7%1.3 $2.24
3/15/202499,400 shares $185.88 thousand +196.7%1.7%1.3 $1.87
2/29/202433,500 shares $73.70 thousand +94.8%0.6%0.5 $2.20
2/15/202417,200 shares $29.93 thousand +18.6%0.3%1.8 $1.74
1/31/202414,500 shares $23.93 thousand -20.8%0.3%1.5 $1.65
1/15/202418,300 shares $33.86 thousand -10.7%0.3%1.3 $1.85
12/31/202320,500 shares $36.08 thousand -9.3%0.4%1.5 $1.76
12/15/202322,600 shares $44.75 thousand -2.6%0.4%1.7 $1.98
11/30/202323,200 shares $52.43 thousand +21.5%0.4%1.4 $2.26
11/15/202319,100 shares $42.02 thousand +64.7%0.3%1 $2.20
10/31/202311,600 shares $26.45 thousand -3.3%0.2%0.5 $2.28
10/15/202312,000 shares $30.72 thousand -14.3%0.2%0.6 $2.56
9/30/202314,000 shares $38.57 thousand -31.7%0.2%0.7 $2.76
9/15/202320,500 shares $69.29 thousand -9.3%0.4%1 $3.38
8/31/202322,600 shares $64.86 thousand -51.6%0.4%1.3 $2.87
8/15/202346,700 shares $104.61 thousand +115.2%0.8%2.8 $2.24
7/31/202321,700 shares $44.92 thousand +29.9%0.4%1.6 $2.07
7/15/202316,700 shares $31.73 thousand -1.8%0.3%1.3 $1.90
6/30/202317,000 shares $32.47 thousand -28.3%0.3%0.6 $1.91
6/15/202323,700 shares $46.45 thousand -11.9%0.4%0.8 $1.96
5/31/202326,900 shares $43.85 thousand -0.4%0.5%0.9 $1.63
5/15/202327,000 shares $56.16 thousand -51.4%0.5%1 $2.08
4/30/202355,600 shares $145.06 thousand +159.8%1.0%2 $2.61
4/15/202321,400 shares $41.73 thousand -9.3%0.4%0.8 $1.95
3/31/202323,600 shares $43.66 thousand -12.6%0.4%3.1 $1.85
3/15/202327,000 shares $41.04 thousand +4.7%0.5%2.9 $1.52
2/28/202325,800 shares $45.15 thousand -21.3%0.5%1 $1.75
2/15/202332,800 shares $58.71 thousand -16.1%0.6%1.3 $1.79
1/31/202339,100 shares $69.21 thousand +3.7%0.7%1.5 $1.77
1/15/202337,700 shares $61.45 thousand -29.8%0.7%1.5 $1.63
12/30/202253,700 shares $77.87 thousand -46.3%1.1%2.2 $1.45
12/15/2022100,000 shares $195 thousand +498.8%2.0%4.2 $1.95
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next! (Ad)

Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starfighter aircraft, giving it a rare platform for high-speed flight testing, captive-carry missions and aerospace research. Its Wind Tunnel in the Sky concept exposes hardware to real high-speed atmospheric conditions, while new collaborations with Vaya Defense & Space and The Bionetics Corporation expand its reach into propulsion, hypersonic test articles and payload processing. FJET is also developing STARLAUNCH, an air-launched system targeting suborbital missions, positioning the company across testing, defense and launch.tc pixel

See how FJET is building the aerospace industry's next testing frontier
11/30/202216,700 shares $30.42 thousand -4.6%0.3%1.6 $1.82
11/15/202217,500 shares $30.28 thousand +5.4%0.4%1.6 $1.73
10/31/202216,600 shares $30.38 thousand +9.2%0.3%1.4 $1.83
10/15/202215,200 shares $27.36 thousand -14.6%0.3%1.1 $1.80
9/30/202217,800 shares $38.45 thousand -21.9%0.4%1.1 $2.16
9/15/202222,800 shares $61.10 thousand -8.1%0.5%0.9 $2.68
8/31/202224,800 shares $62.50 thousand -31.7%0.5%0.7 $2.52
8/15/202236,300 shares $105.27 thousand -36.9%0.7%0.6 $2.90
7/31/202257,500 shares $163.30 thousand -25.3%1.1%0.1 $2.84
7/15/202277,000 shares $256.41 thousand +49.8%1.5%0.2 $3.33
6/30/202251,400 shares $134.15 thousand -42.6%1.0%0.1 $2.61
6/15/202289,500 shares $200.48 thousand -50.9%1.6%0.2 $2.24
5/31/2022182,100 shares $460.71 thousand +569.5%3.2%0.4 $2.53
5/15/202227,200 shares $67.46 thousand -38.3%0.5%0.1 $2.48
4/30/202244,100 shares $129.21 thousand -14.7%0.8%1 $2.93
4/15/202251,700 shares $177.33 thousand -18.1%0.9%0.9 $3.43
3/31/202263,100 shares $252.40 thousand -30.6%1.1%0.8 $4.00
3/15/202290,900 shares $289.97 thousand +21.2%1.6%0.6 $3.19
2/28/202275,000 shares $313.50 thousand +6.8%1.4%0.4 $4.18
2/15/202270,200 shares $351 thousand -34.2%1.3%0.3 $5.00
1/31/2022106,600 shares $531.93 thousand +2.8%1.9%0.4 $4.99
1/15/2022103,700 shares $547.54 thousand +157.3%1.9%0.4 $5.28
12/31/202140,300 shares $229.71 thousand No Change0.7%0.1 $5.70

INDP Short Interest - Frequently Asked Questions

Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 212,357 shares of INDP short. 0.18% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INDP shares currently have a short interest ratio of 0.2. Learn More on Indaptus Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.18% of Indaptus Therapeutics' floating shares are currently sold short.

Indaptus Therapeutics saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 212,357 shares, an increase of 71.6% from the previous total of 123,737 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.18% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Indaptus Therapeutics: ADMA Biologics Inc (11.09%), Mesoblast Limited (3.00%), Hemab Therapeutics Holdings, Inc. (4.51%), Biohaven Ltd. (14.59%), Zymeworks Inc. (10.01%), Lakefront Biotherapeutics American Depositary Shares (5.15%), Stoke Therapeutics, Inc. (19.21%), Septerna, Inc. (6.18%), Nanobiotix S.A. - Sponsored ADR (0.31%), Vir Biotechnology, Inc. (12.99%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($62.68 billion), Invesco QQQ ($47.06 billion), iShares Russell 2000 ETF ($23.54 billion), SPDR S&P Biotech ETF ($12.10 billion), Nebius Group N.V. ($9.34 billion), Western Digital Corporation ($8.96 billion), Financial Select Sector SPDR Fund ($8.16 billion), iShares 20+ Year Treasury Bond ETF ($7.98 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.52 billion), and VanEck Semiconductor ETF ($7.39 billion). View all of the most shorted stocks.

Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is August, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like INDP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:INDP is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...
Banyan Hill Publishing | Sponsoredtc pixel
They're shrinking your dollars every single month
Since 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...
American Alternative | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel